Tzield Injection
Product Images NDC 73650-316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tzield (NDC 73650-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Provention Bio, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Carton (Principal Panel)

Image Of Carton (Principal Panel)
Label for TZIELD injection, teplizumab-mzwv, 1 mg/mL strength provided as 2 mg/2 mL. The label indicates it contains a single dose vial for intravenous infusion, with instructions to discard unused portion and store in the original carton to protect from light. Labeler is Provention Bio, Inc.*
FDA Label Image

Image Of Carton (Principal Panel)

Image Of Carton (Principal Panel)
Label for TZIELD (teplizumab-mzwv) injection, 2 mg/2 mL (1 mg/mL) strength, containing 10 single dose vials. The label indicates it is for intravenous use and instructs to store in the original carton to protect from light. The product is labeled by Provention Bio, Inc. and includes an NDC number 73650-316-10.*
FDA Label Image

Image Of Carton (Principal Panel)

Image Of Carton (Principal Panel)
Label for TZIELD (teplizumab-mzwv) injection, 2 mg/2 mL (1 mg/mL), displaying the dosage form and strength. The label notes that it contains 14 single dose vials and instructs to discard unused portions. It includes storage and handling directions for intravenous infusion and identifies Provention Bio, Inc. as the labeler.*
FDA Label Image

Image Of Figure 1 (Fig 1)

Image Of Figure 1 (Fig 1)
A Kaplan-Meier survival plot showing event-free probability over months up to 87 comparing TZIELD (teplizumab-mzwv) and placebo. The chart includes lines for TZIELD, placebo, and censored data, with tables below showing the number of patients yet to experience Stage 3 type 1 diabetes and cumulative diagnoses by group over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.